1. Home
  2. Analysis
  3. Divalproex-sodium
  4. Strattera

Divalproex sodium and Strattera drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among 8 people who take Divalproex sodium and Strattera. Common interactions include affective disorder among females, and drug dependence among males.

The phase IV clinical study analyzes what interactions people who take Divalproex sodium and Strattera have. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 26, 2023

8 people who take Divalproex sodium and Strattera together, and have interactions are studied.

What is Divalproex sodium?

Divalproex sodium has active ingredients of divalproex sodium. It is used in epilepsy. Currently, eHealthMe is studying from 8,408 Divalproex sodium users.

What is Strattera?

Strattera has active ingredients of atomoxetine hydrochloride. It is used in attention deficit hyperactivity disorder. Currently, eHealthMe is studying from 28,961 Strattera users.

Number of Divalproex sodium and Strattera reports submitted per year:

Divalproex sodium and Strattera drug interactions.

Common Divalproex Sodium and Strattera drug interactions by gender *:

female:

  1. Affective disorder
  2. Alopecia
  3. Drug rash with eosinophilia and systemic symptoms

male:

  1. Drug dependence
  2. Constipation
  3. Renal transplant
  4. Seizure
  5. Urticaria
  6. Vomiting
  7. Diabetes mellitus
  8. Drug ineffective
  9. Hallucination
  10. Intracranial pressure increased

Common Divalproex Sodium and Strattera drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Affective disorder
  2. Drug rash with eosinophilia and systemic symptoms
  3. Intracranial pressure increased
  4. Vomiting

20-29:

n/a

30-39:

  1. Overdose
  2. Renal transplant
  3. Diabetes mellitus

40-49:

  1. Alopecia
  2. Drug ineffective
  3. Pruritus
  4. Urticaria

50-59:

n/a

60+:

  1. Constipation
  2. Hallucination
  3. Nonspecific reaction
  4. Paranoia
  5. Seizure

* Approximation only. Some reports may have incomplete information.

Do you take Divalproex sodium and Strattera?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Drug side effects by duration, gender and age:

Common Divalproex sodium drug interactions:

Browse interactions between Divalproex sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Common Strattera drug interactions:

Browse interactions between Strattera and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on divalproex sodium and atomoxetine hydrochloride (the active ingredients of Divalproex sodium and Strattera, respectively), and Divalproex sodium and Strattera (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study. Patients in the study may take other drugs besides Divalproex sodium and Strattera.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe:

© 2023 eHealthMe.com. All rights reserved. Use of this site constitutes acceptance of eHealthMe.com's terms of service and privacy policy.